Reporter

National type I diabetes prevention trial now an option for younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.

Vanderbilt Kennedy Center to hold free symposium on fragile X

By VUMC News and Communications

Doctors see rise in tick-borne illnesses and other insect-related infections

By VUMC News and Communications

Physical Medicine and Rehabilitation adds new programs

Officially established on April 1, Vanderbilt’s new Department of Physical Medicine and Rehabilitation (PM&R) has welcomed its first new faculty recruit and is establishing clinical and research programs.

By VUMC News and Communications

July 26, 2012

High school student speeds anti-obesity research at VU

A California high school student helped accelerate an anti-obesity drug discovery program at Vanderbilt University this summer — and provided the proof-of-principle for a new technique that could save the lab an estimated $250,000 in the process.

By Bill Snyder

July 26, 2012

Study finds mutation in melanoma sensitive to drug

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.